Exploring The Value Of Clinical Pharmacy Services For Patients With Diabetes In Safety Net Settings | 23545
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Exploring the value of clinical pharmacy services for patients with diabetes in safety net settings

2nd International Summit on Clinical Pharmacy

Yardlee S. Kauffman

Accepted Abstracts: Clinic Pharmacol Biopharm

DOI: 10.4172/2167-065X.S1.008

The role of a pharmacist in safety net settings has not been well studied, specifically in meeting unmet needs of vulnerable patients with diabetes. The objective of this study was to identify unmet management and medication-related needs of patients with diabetes who are receiving care in two distinct underserved practices in Pittsburgh, PA. Individual, semistructured interviews with patients from a Free Clinic (FC) and a Federally Qualified Community Health Center (FQHC) in Pittsburgh were conducted. Inclusion criteria included: adults at least 18 years old with uncontrolled diabetes (A1C > 7%) who received health care services from either the FC or the FQHC. Participants completed a short demographic survey and answered questions about their perceptions and attitudes in four thematic areas: (1) self-management of diabetes; (2) medication-related needs; (3) the role of the pharmacist in their care; and (4) how pharmacists can be better integrated in their diabetes management. Transcripts were analyzed using principles of Grounded Theory. Twenty-nine interviews were conducted: 15 participants were from the FC, and 14 were from the FQHC. Five main themes emerged from each site including: patients experience challenges managing their diabetes, patients identify the emotional struggle associated with living with diabetes, patients feel that they are ?on their own? to care for their diabetes, patients desire a personal and caring relationship with their pharmacist, and patients value a pharmacist who is knowledgeable about diabetes care. These results will help provide guidance to pharmacists working in safety net settings who are interested in expanding clinical pharmacy services for patients with diabetes.
Yardlee S. Kauffman received her PharmD degree from the University of Pittsburgh School of Pharmacy in 2010. Dr. Kauffman completed a PGY1 community practice residency at the University of Pittsburgh Medical Center in 2011 and a PGY2 residency in Ambulatory Care with an emphasis in underserved care and global health at the University of Pittsburgh School of Pharmacy in 2012. She also received a Masters in Public Health from the University of Pittsburgh Graduate School of Public Health in 2012. She is also board certified in both ambulatory care pharmacy and public health. Dr. Kauffman is currently in the final year of a twoyear outcomes research fellowship at Kaiser Permanente Colorado.